AMPK activation protects astrocytes from hypoxia‑induced cell death

Int J Mol Med. 2020 May;45(5):1385-1396. doi: 10.3892/ijmm.2020.4528. Epub 2020 Mar 5.

Abstract

Adenosine monophosphate (AMP)‑activated protein kinase (AMPK) is a major cellular energy sensor that is activated by an increase in the AMP/adenosine triphosphate (ATP) ratio. This causes the initiation of adaptive cellular programs, leading to the inhibition of anabolic pathways and increasing ATP synthesis. AMPK indirectly inhibits mammalian target of rapamycin (mTOR) complex 1 (mTORC1), a serine/threonine kinase and central regulator of cell growth and metabolism, which integrates various growth inhibitory signals, such as the depletion of glucose, amino acids, ATP and oxygen. While neuroprotective approaches by definition focus on neurons, that are more sensitive under cell stress conditions, astrocytes play an important role in the cerebral energy homeostasis during ischemia. Therefore, the protection of astrocytic cells or other glial cells may contribute to the preservation of neuronal integrity and function. In the present study, it was thus hypothesized that a preventive induction of energy deprivation‑activated signaling pathways via AMPK may protect astrocytes from hypoxia and glucose deprivation. Hypoxia‑induced cell death was measured in a paradigm of hypoxia and partial glucose deprivation in vitro in the immortalized human astrocytic cell line SVG. Both the glycolysis inhibitor 2‑deoxy‑d‑glucose (2DG) and the AMPK activator A‑769662 induced the phosphorylation of AMPK, resulting in mTORC1 inhibition, as evidenced by a decrease in the phosphorylation of the target ribosomal protein S6 (RPS6). Treatment with both 2DG and A‑769662 also decreased glucose consumption and lactate production. Furthermore, A‑769662, but not 2DG induced an increase in oxygen consumption, possibly indicating a more efficient glucose utilization through oxidative phosphorylation. Hypoxia‑induced cell death was profoundly reduced by treatment with 2DG or A‑769662. On the whole, the findings of the present study demonstrate, that AMPK activation via 2DG or A‑769662 protects astrocytes under hypoxic and glucose‑depleted conditions.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Biphenyl Compounds
  • Cell Death / drug effects*
  • Deoxyglucose / pharmacology
  • Glucose / metabolism
  • Glycolysis / drug effects
  • Humans
  • Hypoxia / drug therapy*
  • Hypoxia / metabolism
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Oxidative Phosphorylation / drug effects
  • Protective Agents / pharmacology*
  • Pyrones / pharmacology
  • Signal Transduction / drug effects
  • TOR Serine-Threonine Kinases / metabolism
  • Thiophenes / pharmacology

Substances

  • Biphenyl Compounds
  • Protective Agents
  • Pyrones
  • Thiophenes
  • Deoxyglucose
  • TOR Serine-Threonine Kinases
  • AMP-Activated Protein Kinases
  • Glucose
  • 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile